People with attention deficit hyperactivity disorder are being advised to contact their doctor as Australia’s drug regulator warned a common medication used to treat the condition may be in short supply for the rest of the year.
Methylphenidate – known by its brand names as Ritalin, Ritalin LA and Concerta – is in short supply in Australia due to manufacturing issues, according to a notice from the Therapeutic Goods Administration on Wednesday, which advised people to speak to their pharmacist to help source their prescription.
